NgsAdvisory
TR EN
Request a Second Opinion
NgsAdvisory
For physicians For patients & families
02 For patients & families

A second opinion
you can hold
in your hands.

Send your genomic test from home. We turn it into a clear, physician signed strategy, written for your doctor in English, and explained to you in your own language. Available in TR, EN, BG, RO, BA.

Talk to us, free 15 min How it works
No medical advice given to patients. We work alongside your treating physician.
GDPR · KVKK
Files encrypted in transit and at rest before they touch our storage.
5 languages
Native language commentary alongside English clinical report.
Physician signed
Personally reviewed by Prof. Ibrahim Yıldız, MD.
72h delivery
Median turnaround. STAT and priority options available.
03 How it works

From your lab report to a treatment plan
your physician can act on.

Step 01 · Encrypted intake
From your couch, on your phone.

Upload the lab report: Tempus, Foundation, Guardant, Caris, in house panel. PDF or scan, both work. Add a few lines about your diagnosis and current treatment. That's it.

  • Files encrypted in transit and at rest
  • No registration · drop link from your physician works too
  • Family members and caregivers welcome to submit on your behalf
N
Step 02 · Tier graded advisory
Genes turned into a strategy.

Within 72 hours, our team, led by Prof. Yıldız, reads the molecular profile, regrades every finding for your tumor type, and writes a structured 12-section advisory. PARPi, immunotherapy, MEK inhibitors, trials: every option weighed against your specific case.

  • DNA + RNA + IHC reconciled into one truth
  • Tier IB → IV regraded for your tumor type and line
  • 1L → 2L → 3L+ planned today, not at progression
Lab report · raw
KRAS p.G12D
Strategy · for your doctor
1L: Defactinib + Avutometinib

NCCN consensus, with hormonal backbone option. Evidence graded, with trial alternatives.

Step 03 · Direct dialogue
Peer to peer, in your physician's language.

The full English clinical report goes to your treating physician, with a direct line for questions. Phone, email, or video; tumor board attendance on request. Decisions stay with your physician. We hand them the evidence.

  • Discussed peer to peer with your treating oncologist
  • Trial referrals with verified NCT IDs and contact sites
  • Resistance plan ready before progression
Your physician What's the resistance plan if 1L progresses?
NgsAdvisory ctDNA at progression, MAP2K1/2 most common. Monitor NF1 subclone (22.1% baseline).
Your physician Trial options nearby?
NgsAdvisory NCT06299839: Istanbul + global. HLA typing needed for the TCR-T trial.
Step 04 · Native language note
Written so you understand it too.

Alongside the clinical document, you receive a personal letter in your own language: Turkish, English, Bulgarian, Romanian, or Bosnian. What was found, what it means, what the plan is, and what to expect.

  • Plain language summary, not medical jargon
  • Glossary of every clinical term used
  • Yours to keep, share with family, or take to a second hospital
Hasta için özet Sayfa 1/4
Sevgili Elif Hanım,
04 Privacy & ethics

The most personal data you'll ever share.
Treated like it.

Your genomic profile is among the most sensitive data you'll ever generate. We've built our pipeline around that fact, not around it.

  • Encrypted in transit and at rest
    Your data is encrypted in transit (TLS) and at rest with libsodium AEAD (XChaCha20-Poly1305 for uploaded files and XSalsa20-Poly1305 for case data) at the application layer. Master keys live in server configuration outside the web root.
  • GDPR & KVKK aligned
    EU grade (GDPR/KVKK) data handling. You can request full deletion at any time and receive confirmation within 72 hours.
  • Anonymised review
    Internal review uses case codes. Your name appears only on the final signed report and only with your consent.
  • You own your file
    Original files are yours. We don't sell, share, or use them for training data. Permanent deletion on request.
05 Stories

Anonymised, with permission.
Real outcomes.

"They saw a target three other labs missed. We changed the plan in two weeks."
Daughter of patient
LGSC · 31
"My oncologist appreciated how the report was structured. We finally had a 2L plan before progression."
Patient
NSCLC · IV
"Prof. Yıldız called us himself (in Turkish) and walked us through every option."
Spouse of patient
CRC · III
06 Frequently asked

What patients and families
most often ask.

No. You can submit directly. We'll deliver our advisory to you and to any physician you nominate. Many of our cases come from family members of patients.
Any major NGS panel: Tempus xT/xR, FoundationOne CDx, Guardant360, Caris MI, Illumina TSO500, or in house panels from your hospital. PDFs and scans both work.
No. We never replace your treating physician. We work alongside them. Final clinical decisions are exclusively your physician's responsibility. We provide tier graded evidence.
Clinical reports are written in English (the standard for global oncology). You also receive a personal letter in your native language: Turkish, English, Bulgarian, Romanian, or Bosnian.
Median 72 hours from intake. Priority (48 h) and STAT (24 h) options available for time sensitive cases. Please flag urgency on submission.
2,800 USD per case (VAT included) for the structured advisory and physician dialogue. Family of patient discounts and hardship arrangements available. Contact us.
Free 15-minute call

Bring us the report.
We'll meet you where you are.

Talk to us before you decide. No medical advice on this call: only an honest conversation about whether a second molecular review can help.

Book a call [email protected]
NgsAdvisory.

Services

Site

Legal

2026 NGSADVISORY™
For physician use · not a diagnosis